梅特勒-托利多 MTD
$1,722.15 +$43.07 (+2.57%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $1,722.15 0.00%
开盘$1,806.58
昨收$1,679.08
当日区间$1,685.63 – $1,806.58
成交量350.6K
市值$34.51B
市盈率（TTM）37.4
股息率–
MTD 相关新闻
匹配 Mettler-Toledo International 或代码 MTD 的头条新闻，按最新排序。
- Goldman Sachs Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Raises Target Price to $1,510 正面
- Rothschild & Co Redburn Initiates Mettler-Toledo International(MTD.US) With Sell Rating, Announces Target Price $1,200
- RBC Capital Downgrades Mettler-Toledo International(MTD.US) to Hold Rating, Raises Target Price to $1,515 中性
- Mettler-Toledo International(MTD.US) Officer Sells US$3.21 Million in Common Stock
- Morgan Stanley Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Raises Target Price to $1,450 正面
- Barclays Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Raises Target Price to $1,575 正面
- Stifel Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Raises Target Price to $1,600 正面
- Stifel Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Maintains Target Price $1,400
- BofA Securities Maintains Mettler-Toledo International(MTD.US) With Buy Rating
- Jefferies Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Raises Target Price to $1,580 正面
- Citi Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Maintains Target Price $1,550
- Evercore Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Cuts Target Price to $1,350 负面
- Stifel Maintains Mettler-Toledo International(MTD.US) With Buy Rating, Cuts Target Price to $1,400 负面
- Analysts Offer Insights on Healthcare Companies: Mettler-Toledo (MTD) and Neumora Therapeutics, Inc. (NMRA)
- Morgan Stanley Maintains Mettler-Toledo International(MTD.US) With Hold Rating, Cuts Target Price to $1,078.53 负面
暂无评论——快来第一个聊聊 MTD。